[시장보고서]신경과학 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

신경과학 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Neuroscience Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

상품코드 : 1459785

리서치사 : Transparency Market Research

발행일 : 2024년 02월

페이지 정보 : 영문 182 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,352,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 12,676,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,000,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

신경과학 시장 - 조사범위

TMR의 세계 신경과학 시장 조사 보고서는 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2023년을 기준 연도, 2031년을 예측 연도로 하여 2017년부터 2031년까지 신경과학 세계 시장 수익과 예측을 제공합니다. 또한 2023년부터 2031년까지 신경과학 세계 시장의 연평균 성장률(CAGR%)도 제시합니다.

이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서는 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료 및 관련 문서를 참조하여 신경과학 시장을 이해하고자 했습니다. 참고했습니다.

시장 현황
2022년 시장 규모	301억 달러
2031년 시장 가치	416억 달러
CAGR	3.7%

이 보고서는 세계 신경과학 시장 경쟁 구도를 심층적으로 분석합니다. 세계 신경과학 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 개발 및 SWOT는 세계 신경과학 시장에서 활동하는 기업의 속성입니다.

시장 경쟁 매트릭스(Tier별, 기업 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
- NEURALINK
- Kernel
- BrainCo, Inc.
- MindMaze
- Paradromics
- NeuroPro
- NeuroSky
- EMOTIV, Inc.
- Cercare Medical A/S
- Plexon, Inc.
- Noldus Information Technology B.V.
- Femtonics Ltd.
- Neuralynx, Inc.
- Neurable, Inc.
- Bitbrain Technologies
- Halo
- NeuroNexus Technologies, Inc.

LSH

영문 목차

영문목차

Neuroscience Market - Scope of Report

TMR's report on the global neurosciences market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global neurosciences market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurosciences market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the neurosciences market.

Market Snapshot
Market Value in 2022	US$ 30.1 Bn
Market Value in 2031	US$ 41.6 Bn
CAGR	3.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurosciences market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global neurosciences market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurosciences market.

The report delves into the competitive landscape of the global neurosciences market. Key players operating in the global neurosciences market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global neurosciences market profiled in this report.

Key Questions Answered in Global neurosciences Market Report:

What is the sales/revenue generated by neurosciences across all regions during the forecast period?
What are the opportunities in the global neurosciences market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Neuroscience Market - Research Objectives and Research Approach

The comprehensive report on the global neurosciences market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global neurosciences market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global neurosciences market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Neuroscience Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Neuroscience Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Neuroscience Market Analysis and Forecast, by Component

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Component, 2017-2031
- 6.3.1. Instrument
- 6.3.2. Software
- 6.3.3. Services
6.4. Market Attractiveness Analysis, by Component

7. Global Neuroscience Market Analysis and Forecast, by Technology

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017-2031
- 7.3.1. Whole Brain Imaging
- 7.3.2. Neuro-microscopy
- 7.3.3. Electrophysiology
- 7.3.4. Neuroproteomics Analysis
- 7.3.5. Animal Behavior Analysis
- 7.3.6. Neuro-functional Analysis
- 7.3.7. Others
7.4. Market Attractiveness Analysis, by Technology

8. Global Neuroscience Market Analysis and Forecast, by End-user

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Diagnostic Laboratories
- 8.3.3. Academic & Research Institutions
- 8.3.4. Others
8.4. Market Attractiveness Analysis, by Technology

9. Global Neuroscience Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Neuroscience Market Analysis and Forecast

10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Component, 2017-2031
- 10.3.1. Instrument
- 10.3.2. Software
- 10.3.3. Services
10.4. Market Value Forecast, by Technology, 2017-2031
- 10.4.1. Whole Brain Imaging
- 10.4.2. Neuro-microscopy
- 10.4.3. Electrophysiology
- 10.4.4. Neuroproteomics Analysis
- 10.4.5. Animal Behavior Analysis
- 10.4.6. Neuro-functional Analysis
- 10.4.7. Others
10.5. Market Value Forecast, by End-user, 2017-2031
- 10.5.1. Hospitals
- 10.5.2. Diagnostic Laboratories
- 10.5.3. Academic & Research Institutions
- 10.5.4. Others
10.6. Market Value Forecast, by Country, 2017-2031
- 10.6.1. U.S.
- 10.6.2. Canada
10.7. Market Attractiveness Analysis
- 10.7.1. By Component
- 10.7.2. By Technology
- 10.7.3. By End-user
- 10.7.4. By Country

11. Europe Neuroscience Market Analysis and Forecast

11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Component, 2017-2031
- 11.3.1. Instrument
- 11.3.2. Software
- 11.3.3. Services
11.4. Market Value Forecast, by Technology, 2017-2031
- 11.4.1. Whole Brain Imaging
- 11.4.2. Neuro-microscopy
- 11.4.3. Electrophysiology
- 11.4.4. Neuroproteomics Analysis
- 11.4.5. Animal Behavior Analysis
- 11.4.6. Neuro-functional Analysis
- 11.4.7. Others
11.5. Market Value Forecast, by End-user, 2017-2031
- 11.5.1. Hospitals
- 11.5.2. Diagnostic Laboratories
- 11.5.3. Academic & Research Institutions
- 11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.6.1. Germany
- 11.6.2. U.K.
- 11.6.3. France
- 11.6.4. Italy
- 11.6.5. Spain
- 11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
- 11.7.1. By Component
- 11.7.2. By Technology
- 11.7.3. By End-user
- 11.7.4. By Country/Sub-region

12. Asia Pacific Neuroscience Market Analysis and Forecast

12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Component, 2017-2031
- 12.3.1. Instrument
- 12.3.2. Software
- 12.3.3. Services
12.4. Market Value Forecast, by Technology, 2017-2031
- 12.4.1. Whole Brain Imaging
- 12.4.2. Neuro-microscopy
- 12.4.3. Electrophysiology
- 12.4.4. Neuroproteomics Analysis
- 12.4.5. Animal Behavior Analysis
- 12.4.6. Neuro-functional Analysis
- 12.4.7. Others
12.5. Market Value Forecast, by End-user, 2017-2031
- 12.5.1. Hospitals
- 12.5.2. Diagnostic Laboratories
- 12.5.3. Academic & Research Institutions
- 12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. China
- 12.6.2. Japan
- 12.6.3. India
- 12.6.4. Australia & New Zealand
- 12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
- 12.7.1. By Component
- 12.7.2. By Technology
- 12.7.3. By End-user
- 12.7.4. By Country/Sub-region

13. Latin America Neuroscience Market Analysis and Forecast

13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Component, 2017-2031
- 13.3.1. Instrument
- 13.3.2. Software
- 13.3.3. Services
13.4. Market Value Forecast, by Technology, 2017-2031
- 13.4.1. Whole Brain Imaging
- 13.4.2. Neuro-microscopy
- 13.4.3. Electrophysiology
- 13.4.4. Neuroproteomics Analysis
- 13.4.5. Animal Behavior Analysis
- 13.4.6. Neuro-functional Analysis
- 13.4.7. Others
13.5. Market Value Forecast, by End-user, 2017-2031
- 13.5.1. Hospitals
- 13.5.2. Diagnostic Laboratories
- 13.5.3. Academic & Research Institutions
- 13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. Brazil
- 13.6.2. Mexico
- 13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
- 13.7.1. By Component
- 13.7.2. By Technology
- 13.7.3. By End-user
- 13.7.4. By Country/Sub-region

14. Middle East & Africa Neuroscience Market Analysis and Forecast

14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Component, 2017-2031
- 14.3.1. Instrument
- 14.3.2. Software
- 14.3.3. Services
14.4. Market Value Forecast, by Technology, 2017-2031
- 14.4.1. Whole Brain Imaging
- 14.4.2. Neuro-microscopy
- 14.4.3. Electrophysiology
- 14.4.4. Neuroproteomics Analysis
- 14.4.5. Animal Behavior Analysis
- 14.4.6. Neuro-functional Analysis
- 14.4.7. Others
14.5. Market Value Forecast, by End-user, 2017-2031
- 14.5.1. Hospitals
- 14.5.2. Diagnostic Laboratories
- 14.5.3. Academic & Research Institutions
- 14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. GCC Countries
- 14.6.2. South Africa
- 14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
- 14.7.1. By Component
- 14.7.2. By Technology
- 14.7.3. By End-user
- 14.7.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
- 15.3.1. NEURALINK
  - 15.3.1.1. Company Overview
  - 15.3.1.2. Product Portfolio
  - 15.3.1.3. SWOT Analysis
  - 15.3.1.4. Financial Overview
  - 15.3.1.5. Strategic Overview
- 15.3.2. Kernel
  - 15.3.2.1. Company Overview
  - 15.3.2.2. Product Portfolio
  - 15.3.2.3. SWOT Analysis
  - 15.3.2.4. Financial Overview
  - 15.3.2.5. Strategic Overview
- 15.3.3. BrainCo, Inc.
  - 15.3.3.1. Company Overview
  - 15.3.3.2. Product Portfolio
  - 15.3.3.3. SWOT Analysis
  - 15.3.3.4. Financial Overview
  - 15.3.3.5. Strategic Overview
- 15.3.4. MindMaze
  - 15.3.4.1. Company Overview
  - 15.3.4.2. Product Portfolio
  - 15.3.4.3. SWOT Analysis
  - 15.3.4.4. Financial Overview
  - 15.3.4.5. Strategic Overview
- 15.3.5. Paradromics
  - 15.3.5.1. Company Overview
  - 15.3.5.2. Product Portfolio
  - 15.3.5.3. SWOT Analysis
  - 15.3.5.4. Financial Overview
  - 15.3.5.5. Strategic Overview
- 15.3.6. NeuroPro
  - 15.3.6.1. Company Overview
  - 15.3.6.2. Product Portfolio
  - 15.3.6.3. SWOT Analysis
  - 15.3.6.4. Financial Overview
  - 15.3.6.5. Strategic Overview
- 15.3.7. NeuroSky
  - 15.3.7.1. Company Overview
  - 15.3.7.2. Product Portfolio
  - 15.3.7.3. SWOT Analysis
  - 15.3.7.4. Financial Overview
  - 15.3.7.5. Strategic Overview
- 15.3.8. EMOTIV, Inc.
  - 15.3.8.1. Company Overview
  - 15.3.8.2. Product Portfolio
  - 15.3.8.3. SWOT Analysis
  - 15.3.8.4. Financial Overview
  - 15.3.8.5. Strategic Overview
- 15.3.9. Cercare Medical A/S
  - 15.3.9.1. Company Overview
  - 15.3.9.2. Product Portfolio
  - 15.3.9.3. SWOT Analysis
  - 15.3.9.4. Financial Overview
  - 15.3.9.5. Strategic Overview
- 15.3.10. Plexon, Inc.
  - 15.3.10.1. Company Overview
  - 15.3.10.2. Product Portfolio
  - 15.3.10.3. SWOT Analysis
  - 15.3.10.4. Financial Overview
  - 15.3.10.5. Strategic Overview
- 15.3.11. Noldus Information Technology B.V.
  - 15.3.11.1. Company Overview
  - 15.3.11.2. Product Portfolio
  - 15.3.11.3. SWOT Analysis
  - 15.3.11.4. Financial Overview
  - 15.3.11.5. Strategic Overview
- 15.3.12. Femtonics Ltd.
  - 15.3.12.1. Company Overview
  - 15.3.12.2. Product Portfolio
  - 15.3.12.3. SWOT Analysis
  - 15.3.12.4. Financial Overview
  - 15.3.12.5. Strategic Overview
- 15.3.13. Neuralynx, Inc.
  - 15.3.13.1. Company Overview
  - 15.3.13.2. Product Portfolio
  - 15.3.13.3. SWOT Analysis
  - 15.3.13.4. Financial Overview
  - 15.3.13.5. Strategic Overview
- 15.3.14. Neurable, Inc.
  - 15.3.14.1. Company Overview
  - 15.3.14.2. Product Portfolio
  - 15.3.14.3. SWOT Analysis
  - 15.3.14.4. Financial Overview
  - 15.3.14.5. Strategic Overview
- 15.3.15. Bitbrain Technologies
  - 15.3.15.1. Company Overview
  - 15.3.15.2. Product Portfolio
  - 15.3.15.3. SWOT Analysis
  - 15.3.15.4. Financial Overview
  - 15.3.15.5. Strategic Overview
- 15.3.16. Halo Neuroscience
  - 15.3.16.1. Company Overview
  - 15.3.16.2. Product Portfolio
  - 15.3.16.3. SWOT Analysis
  - 15.3.16.4. Financial Overview
  - 15.3.16.5. Strategic Overview
- 15.3.17. NeuroNexus Technologies, Inc.
  - 15.3.17.1. Company Overview
  - 15.3.17.2. Product Portfolio
  - 15.3.17.3. SWOT Analysis
  - 15.3.17.4. Financial Overview
  - 15.3.17.5. Strategic Overview

한글목차

신경과학 시장 - 조사범위

목차

제1장 서문

제2장 조사의 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

제5장 주요 인사이트

제6장 세계 시장 분석과 예측 : 컴포넌트별

제7장 세계 시장 분석과 예측 : 기술별

제8장 세계 시장 분석과 예측 : 최종사용자별

제9장 세계 시장 분석과 예측 : 지역별

제10장 북미 시장 분석과 예측

제11장 유럽 시장 분석과 예측

제12장 아시아태평양 시장 분석과 예측

제13장 라틴아메리카 시장 분석과 전망

제14장 중동 및 아프리카 시장 분석과 전망

제15장 경쟁 환경 경쟁 구도